rs3207909

Variant summary

Our verdict is Benign. The variant received -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BA1

The NM_001393392.1(AKR1C2):​c.441A>G​(p.Thr147Thr) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.148 in 126,644 control chromosomes in the GnomAD database, including 1,255 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.15 ( 1255 hom., cov: 30)
Exomes 𝑓: 0.24 ( 18268 hom. )
Failed GnomAD Quality Control

Consequence

AKR1C2
NM_001393392.1 synonymous

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:5

Conservation

PhyloP100: -9.11

Publications

8 publications found
Variant links:
Genes affected
AKR1C2 (HGNC:385): (aldo-keto reductase family 1 member C2) This gene encodes a member of the aldo/keto reductase superfamily, which consists of more than 40 known enzymes and proteins. These enzymes catalyze the conversion of aldehydes and ketones to their corresponding alcohols using NADH and/or NADPH as cofactors. The enzymes display overlapping but distinct substrate specificity. This enzyme binds bile acid with high affinity, and shows minimal 3-alpha-hydroxysteroid dehydrogenase activity. This gene shares high sequence identity with three other gene members and is clustered with those three genes at chromosome 10p15-p14. Three transcript variants encoding two different isoforms have been found for this gene. [provided by RefSeq, Dec 2011]
AKR1C2 Gene-Disease associations (from GenCC):
  • 46,XY disorder of sex development due to testicular 17,20-desmolase deficiency
    Inheritance: AR Classification: SUPPORTIVE, LIMITED Submitted by: Labcorp Genetics (formerly Invitae), Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -21 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.93).
BP6
Variant 10-4999206-T-C is Benign according to our data. Variant chr10-4999206-T-C is described in ClinVar as Benign. ClinVar VariationId is 434114.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=-9.11 with no splicing effect.
BA1
GnomAd4 highest subpopulation (NFE) allele frequency at 95% confidence interval = 0.208 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
AKR1C2NM_001393392.1 linkc.441A>G p.Thr147Thr synonymous_variant Exon 4 of 9 ENST00000380753.9 NP_001380321.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
AKR1C2ENST00000380753.9 linkc.441A>G p.Thr147Thr synonymous_variant Exon 4 of 9 1 NM_001393392.1 ENSP00000370129.4 P52895-1
AKR1C2ENST00000421196.7 linkc.370-459A>G intron_variant Intron 3 of 7 1 ENSP00000392694.2 B4DK69
AKR1C2ENST00000604507.5 linkc.441A>G p.Thr147Thr synonymous_variant Exon 5 of 7 5 ENSP00000474566.1 S4R3P0
AKR1C2ENST00000460124.5 linkn.1901A>G non_coding_transcript_exon_variant Exon 3 of 8 5

Frequencies

GnomAD3 genomes
AF:
0.148
AC:
18720
AN:
126554
Hom.:
1256
Cov.:
30
show subpopulations
Gnomad AFR
AF:
0.0672
Gnomad AMI
AF:
0.221
Gnomad AMR
AF:
0.146
Gnomad ASJ
AF:
0.187
Gnomad EAS
AF:
0.0118
Gnomad SAS
AF:
0.0794
Gnomad FIN
AF:
0.156
Gnomad MID
AF:
0.0984
Gnomad NFE
AF:
0.211
Gnomad OTH
AF:
0.171
GnomAD2 exomes
AF:
0.221
AC:
40416
AN:
183290
AF XY:
0.226
show subpopulations
Gnomad AFR exome
AF:
0.0870
Gnomad AMR exome
AF:
0.144
Gnomad ASJ exome
AF:
0.315
Gnomad EAS exome
AF:
0.0880
Gnomad FIN exome
AF:
0.224
Gnomad NFE exome
AF:
0.294
Gnomad OTH exome
AF:
0.249
GnomAD4 exome
Data not reliable, filtered out with message: AS_VQSR
AF:
0.239
AC:
271372
AN:
1137816
Hom.:
18268
Cov.:
33
AF XY:
0.236
AC XY:
133205
AN XY:
565314
show subpopulations
African (AFR)
AF:
0.0721
AC:
2025
AN:
28078
American (AMR)
AF:
0.138
AC:
5106
AN:
36900
Ashkenazi Jewish (ASJ)
AF:
0.254
AC:
4903
AN:
19292
East Asian (EAS)
AF:
0.0349
AC:
1031
AN:
29548
South Asian (SAS)
AF:
0.124
AC:
8186
AN:
65844
European-Finnish (FIN)
AF:
0.190
AC:
7886
AN:
41570
Middle Eastern (MID)
AF:
0.204
AC:
841
AN:
4124
European-Non Finnish (NFE)
AF:
0.267
AC:
231057
AN:
865036
Other (OTH)
AF:
0.218
AC:
10337
AN:
47424
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.477
Heterozygous variant carriers
0
9628
19256
28885
38513
48141
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
8398
16796
25194
33592
41990
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.148
AC:
18719
AN:
126644
Hom.:
1255
Cov.:
30
AF XY:
0.143
AC XY:
8860
AN XY:
61742
show subpopulations
African (AFR)
AF:
0.0670
AC:
2393
AN:
35732
American (AMR)
AF:
0.145
AC:
1856
AN:
12776
Ashkenazi Jewish (ASJ)
AF:
0.187
AC:
496
AN:
2646
East Asian (EAS)
AF:
0.0119
AC:
51
AN:
4294
South Asian (SAS)
AF:
0.0798
AC:
319
AN:
3996
European-Finnish (FIN)
AF:
0.156
AC:
1357
AN:
8716
Middle Eastern (MID)
AF:
0.0955
AC:
21
AN:
220
European-Non Finnish (NFE)
AF:
0.211
AC:
11761
AN:
55758
Other (OTH)
AF:
0.170
AC:
296
AN:
1742
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.513
Heterozygous variant carriers
0
780
1561
2341
3122
3902
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
208
416
624
832
1040
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.197
Hom.:
247

ClinVar

Significance: Benign
Submissions summary: Benign:5
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:2
Jul 05, 2018
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

not specified Benign:1
Nov 11, 2015
Genetic Services Laboratory, University of Chicago
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

46,XY disorder of sex development due to testicular 17,20-desmolase deficiency Benign:1
May 28, 2019
Mendelics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

AKR1C2-related disorder Benign:1
Nov 21, 2019
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

This variant is classified as benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.93
CADD
Benign
5.0
DANN
Benign
0.47
PhyloP100
-9.1
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.060
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs3207909; hg19: chr10-5041398; COSMIC: COSV66332774; COSMIC: COSV66332774; API